1-1 of 1
Christopher von Roretz
Close
Sort by
Journal Articles

Characterization of Bortezomib (Velcade ™) Resistance in a New Set of Human Cell Lines Obtained by Stepwise Selection.

Jie Cai, Ph.D., Xian Jin Lian, M.Sc., Christopher von Roretz, Chaim Shustik, MD, Imed Gallouzi, Philippe Gros, Ph.D.
Journal: Blood
Blood (2009) 114 (22): 2741.
https://doi.org/10.1182/blood.V114.22.2741.2741
Published: 2009